• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于心脏瓣膜移植物的顺应性监测的生物反应器。

A bioreactor with compliance monitoring for heart valve grafts.

机构信息

Department of Bioengineering, Politecnico di Milano, P.za Leonardo da Vinci, 32, 20133, Milan, Italy.

出版信息

Ann Biomed Eng. 2010 Jan;38(1):100-8. doi: 10.1007/s10439-009-9803-1. Epub 2009 Sep 22.

DOI:10.1007/s10439-009-9803-1
PMID:19784774
Abstract

The drawbacks of state-of-the-art heart valve prostheses lead researchers to explore the prospect of using tissue-engineered constructs as possible valve substitutes. It is widely accepted that the mechanical properties of the construct are improved with mechanical stimulation during in vitro growth. We designed a new dynamic bioreactor with the perspective of using decellularized valve homografts as scaffolds in order to produce tissue-engineered valve substitutes. The design guidelines were (a) compatibility with the procedures for the treatment of homografts; (b) delivery of finely controlled pulsatile pressure loads, which induce strain stimuli that may drive cells toward repopulation of and integration with the natural scaffold; and (c) monitoring the construct's biomechanical status through a comprehensive index, i.e., its compliance. The handling needs during the set-up of the homograft and the use of the bioreactor were minimized. The bioreactor and its automated control system underwent tests with a compliant phantom valve. The estimated compliances are in good agreement with the measured ones. Tests were also carried out with porcine aortic samples in order to assess the hydrodynamic and biomechanical reliability. In the future, monitoring the construct's compliance might represent a key factor in controlling the recellularization of the valve homografts, which provides awareness of the construct's biomechanical status by real-time, non-destructive, and non-invasive means.

摘要

最先进的心脏瓣膜假体存在一些缺陷,这促使研究人员探索使用组织工程构建体作为可能的瓣膜替代物的前景。人们普遍认为,在体外生长过程中,通过机械刺激可以改善构建体的机械性能。我们设计了一种新型的动态生物反应器,使用脱细胞瓣膜同种移植物作为支架,以生产组织工程瓣膜替代物。设计指南包括:(a)与同种移植物处理程序兼容;(b)传递精细控制的脉动压力负荷,这些负荷会产生应变刺激,促使细胞重新填充并与天然支架整合;(c)通过综合指标(即顺应性)监测构建体的生物力学状态。在设置同种移植物和使用生物反应器时,尽量减少操作需求。生物反应器及其自动化控制系统已通过顺应性模拟瓣膜进行了测试。估计的顺应性与测量值吻合良好。还对猪主动脉样本进行了测试,以评估水动力和生物力学的可靠性。在未来,监测构建体的顺应性可能成为控制瓣膜同种移植物再细胞化的关键因素,通过实时、非破坏性和非侵入性的手段,可以了解构建体的生物力学状态。

相似文献

1
A bioreactor with compliance monitoring for heart valve grafts.用于心脏瓣膜移植物的顺应性监测的生物反应器。
Ann Biomed Eng. 2010 Jan;38(1):100-8. doi: 10.1007/s10439-009-9803-1. Epub 2009 Sep 22.
2
Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.使用冷冻保存的脐血管细胞进行自体人体心脏瓣膜的组织工程。
Ann Thorac Surg. 2006 Jun;81(6):2207-16. doi: 10.1016/j.athoracsur.2005.12.073.
3
Optical monitoring during bioreactor conditioning of tissue-engineered heart valves.在组织工程心脏瓣膜的生物反应器培养过程中的光学监测。
ASAIO J. 2010 May-Jun;56(3):228-31. doi: 10.1097/MAT.0b013e3181cf3bdd.
4
Deformation-controlled load application in heart valve tissue engineering.变形控制的心脏瓣膜组织工程中的载荷施加。
Tissue Eng Part C Methods. 2009 Dec;15(4):707-16. doi: 10.1089/ten.TEC.2008.0658.
5
Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.周期性弯曲和层流协同加速间充质干细胞介导的工程组织形成:对工程心脏瓣膜组织的启示。
Biomaterials. 2006 Dec;27(36):6083-95. doi: 10.1016/j.biomaterials.2006.07.045. Epub 2006 Aug 23.
6
Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations.用于组织工程心脏瓣膜的细胞、支架和生物反应器:从基本概念到当代发展创新的历程。
Eur J Cardiothorac Surg. 2011 Apr;39(4):523-31. doi: 10.1016/j.ejcts.2010.07.030. Epub 2010 Dec 15.
7
A new approach to heart valve tissue engineering: mimicking the heart ventricle with a ventricular assist device in a novel bioreactor.一种新的心脏瓣膜组织工程方法:在新型生物反应器中使用心室辅助装置模拟心室。
J Tissue Eng Regen Med. 2011 Apr;5(4):292-300. doi: 10.1002/term.315.
8
In vitro fabrication of a tissue engineered human cardiovascular patch for future use in cardiovascular surgery.用于未来心血管手术的组织工程化人体心血管补片的体外制造。
Ann Thorac Surg. 2006 Jan;81(1):57-63. doi: 10.1016/j.athoracsur.2005.07.013.
9
The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.通过优化动态条件培养实现自体纤维蛋白基组织工程心脏瓣膜的体外发育
Biomaterials. 2007 Aug;28(23):3388-97. doi: 10.1016/j.biomaterials.2007.04.012. Epub 2007 Apr 13.
10
A new bioreactor for the development of tissue-engineered heart valves.一种用于组织工程心脏瓣膜研发的新型生物反应器。
Ann Biomed Eng. 2009 Apr;37(4):674-81. doi: 10.1007/s10439-009-9646-9. Epub 2009 Jan 23.

引用本文的文献

1
A versatile modular bioreactor platform for Tissue Engineering.一种用于组织工程的多功能模块化生物反应器平台。
Biotechnol J. 2017 Feb;12(2). doi: 10.1002/biot.201600326. Epub 2016 Sep 26.
2
A Pulsatile Bioreactor for Conditioning of Tissue-Engineered Cardiovascular Constructs under Endoscopic Visualization.一种用于在内窥镜可视化条件下对组织工程心血管构建体进行预处理的搏动生物反应器。
J Funct Biomater. 2012 Jul 19;3(3):480-96. doi: 10.3390/jfb3030480.
3
Tissue engineering of heart valves: PEGylation of decellularized porcine aortic valve as a scaffold for in vitro recellularization.
心脏瓣膜组织工程:去细胞猪主动脉瓣的聚乙二醇化作为体外再细胞化的支架。
Biomed Eng Online. 2013 Sep 5;12:87. doi: 10.1186/1475-925X-12-87.
4
New technologies for surgery of the congenital cardiac defect.先天性心脏缺陷手术的新技术。
Rambam Maimonides Med J. 2013 Jul 25;4(3):e0019. doi: 10.5041/RMMJ.10119. Print 2013 Jul.